Taiwan (TW)

Polygenic prediction of body mass index and obesity through the life course and across ancestries (2025) Smit RA, Wade KH, Hui Q, Arias JD, Yin X, Christiansen MR, Yengo L, et al. Journal article Lymph node mapping-based optimal bowel-resection margin and central radicality in colon cancer surgery: an international, prospective, observational cohort study (2025) Ueno H, Kim NK, Kim JC, Tsarkov P, Hohenberger W, Grützmann R, Samalavičius NE, et al. Journal article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Obstructive Coronary Artery Disease Improved Prediction by the COME-CCT Pretest Probability Calculator With Cardiac CT (2025) Wieske V, Walther M, Mohamed M, Weickert B, Andrzejewski S, Dubourg B, Andreini D, et al. Journal article Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial (2025) Marx N, Deanfield JE, Mann JF, Arechavaleta R, Bain SC, Bajaj HS, Bayer Tanggaard K, et al. Journal article Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial (2025) Fasching P, Slamon D, Nowecki Z, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, et al. Journal article The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset (2025) Fornaro M, Venerito V, Pellico MR, Iannone F, Joshi M, Chen YM, Tan AL, et al. Journal article, Review article Community estimate of global glacier mass changes from 2000 to 2023 (2025) Zemp M, Jakob L, Dussaillant I, Nussbaumer SU, Gourmelen N, Dubber S, A G, et al. Journal article Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study (2025) Hoff LS, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article A phase III trial of adjuvant ribociclib plus endocrine therapy versus endocrine therapy alone in patients with HR-positive/HER2-negative early breast cancer: final invasive disease-free survival results from the NATALEE trial (2025) Hortobagyi GN, Lacko A, Sohn J, Cruz F, Ruiz Borrego M, Manikhas A, Hee Park Y, et al. Journal article